AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 16600443
Drug: RIX4414 vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RIX4414 vaccine (104.7, 105.2, or 106.1 ffu)
Trial: 10348579
Drug: Adjunctive abciximab
RxNorm normalized name: Abciximab
DrugBank: Abciximab (DB00054)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Adjunctive abciximab
Trial: 1359666
Drug: Inhaled corticosteroid
RxNorm normalized name: CORTICOSTEROIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled corticosteroid
Trial: 24837064
Drug: No Treatment
RxNorm normalized name: NO
DrugBank: Nitric Oxide (DB00435)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: No Treatment Control
Trial: 29733403
Drug: Weekly supplementation
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Weekly supplementation (60 mg iron and 2.8 mg folic acid)
Trial: 12453954
Drug: Tadalafil 20
RxNorm normalized name: tadalafil 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tadalafil 20 mg
Trial: 24602553
Drug: Hormone therapy
RxNorm normalized name: INVESTIGATIONAL HORMONE THERAPY/REPLACEMENT,OTHER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hormone therapy (HT)
Trial: 7768272
Drug: 7.5 mg
RxNorm normalized name: biotin 7.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7.5 mg glyburide
Trial: 27344831
Drug: Point application
RxNorm normalized name: ActivOn Joint & Muscle
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Point application treatment using herbal plaster on acupoints Dingchuan (EX-B1), Feishu (BL 13), Gaohuang (BL 43), and Danzhong (CV 17) for 2 to 4 hours on the first day of each of the three periods of the hot season.
Trial: 15782623
Drug: Interferon alfa-2b
RxNorm normalized name: Interferon Alfa-2B
DrugBank: Interferon alfa-2b (DB00105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Interferon alfa-2b at 6MIUs.c./three-times-weekly (group A)
Trial: 7954244
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose (48.0 Gy or 54.4 Gy)
Trial: 16682611
Drug: Transdermal GTN
RxNorm normalized name: GTN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal GTN (5 mg)
Trial: 26874557
Drug: Clonidine 300
RxNorm normalized name: Clonidine
DrugBank: Clonidine (DB00575)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clonidine 300 μg oral premedication administered 90 minutes before surgery
Trial: 7378674
Drug: Iotroxamide infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Iotroxamide infusion
Trial: 9695133
Drug: Lupron injections
RxNorm normalized name: Lupron Injectable Product
DrugBank: Leuprolide (DB00007)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lupron injections (GnRH agonist) followed by transdermal estradiol (Patch)
Trial: 30241510
Drug: CYD‐TDV accelerated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CYD‐TDV accelerated schedule with YF co‐administered
Trial: 10509552
Drug: Fosinopril and
RxNorm normalized name: fosinopril and diuretics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fosinopril and HCTZ with ibuprofen
Trial: 7815656
Drug: Zidovudine at
RxNorm normalized name: Zidovudine
DrugBank: Zidovudine (DB00495)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Zidovudine at 200 mg (later 100 mg) every 4 hours
Trial: 1901808
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg ponalrestat
Trial: 26890736
Drug: Metformin 1000
RxNorm normalized name: metformin 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin 1000 mg twice a day
Trial: 26890736
Drug: Metformin 500
RxNorm normalized name: metformin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin 500 mg/day
Trial: 16084880
Drug: Low-dose hCG
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose hCG (200 IU/day) alone after ovarian priming with recombinant FSH/hMG (group B)
Trial: 28950424
Drug: Testosterone administration
RxNorm normalized name: Testosterone
DrugBank: (1,2,6,7-3H)Testosterone (DB14093)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone administration
Trial: 29588972
Drug: Lacosamide 600
RxNorm normalized name: Lacosamide
DrugBank: Lacosamide (DB06218)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Lacosamide 600 mg/day
Trial: 19687343
Drug: Atorvastatin (ATOR)
DrugBank: Atorvastatin (DB01076)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Atorvastatin (ATOR) 80 mg/d for 12 weeks
Trial: 29050507
Drug: Progressive resistance
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Progressive resistance strength training (twice a week for 12 weeks, load of 50% and 70% of one repetition maximum)
Trial: 27893326
Drug: Cisplatin and
RxNorm normalized name: A micelle drug formulation composed of cisplatin and mPEG-poly(l-Glu) diblock copolymer with 1,3-propanediyl linkagecisplatin is incorporated in polymeric micelles via polymer-metal complex formation with cis-geometry of PT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisplatin and gemcitabine (platinum therapy)
Trial: 10443658
Drug: Insulin analog
RxNorm normalized name: insulin analog, glargine 300 UNT Pen Injector
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin analog (Lispro)
Trial: 10443658
Drug: Regular insulin
RxNorm normalized name: Regular insulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular insulin (Velosuline)
Trial: 23415779
Drug: Topical cyclosporine
RxNorm normalized name: Cyclosporine
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical cyclosporine A 0.05% emulsion twice daily for 3 months postoperatively
Trial: 31462489
Drug: treatment as
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: treatment as usual alone
Trial: 31462489
Drug: six-session VR
RxNorm normalized name: Prostin VR
DrugBank: Alprostadil (DB00770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: six-session VR cognitive treatment added to treatment as usual
Trial: 15231854
Drug: Whisky consumption
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Whisky consumption (40 g of alcohol daily for 17 days)
Trial: 26537944
Drug: 70 g
RxNorm normalized name: alcohol .70 g in 1 g TOPICAL GEL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 70 g pure whey protein isolate (H)
Trial: 3520160
Drug: Infusion of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infusion of glucose, insulin, and potassium
Trial: 11703474
Drug: Subcutaneous sumatriptan
RxNorm normalized name: Sumatriptan
DrugBank: Sumatriptan (DB00669)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Subcutaneous sumatriptan 6 mg
Trial: 23881958
Drug: Simvastatin plus
RxNorm normalized name: Simvastatin
DrugBank: Simvastatin (DB00641)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Simvastatin plus extended-release niacin (ERN) (1500-2000 mg/d)
Trial: 17720079
Drug: Intravitreal injection
RxNorm normalized name: Eylea 2 MG per 0.05 ML Intravitreal Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravitreal injection of triamcinolone acetonide
Trial: 19301232
Drug: Insulin lispro
RxNorm normalized name: Insulin Lispro
DrugBank: Insulin lispro (DB00046)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Insulin lispro mix 50 (50% lispro, 50% insulin lispro protamine suspension) pre-breakfast and lispro mix 25 (25% lispro, 75% insulin lispro protamine suspension)
Trial: 20555293
Drug: Chlorhexidine gel
RxNorm normalized name: chlorhexidine Oral Gel
DrugBank: Chlorhexidine (DB00878)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chlorhexidine gel
Trial: 20345708
Drug: Blocking antibody
RxNorm normalized name: Blocking antibody
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Blocking antibody against PAI-1
Trial: 8739857
Drug: anti-CD4 monoclonal
RxNorm normalized name: Anti-VEGF monoclonal antibody
DrugBank: Bevacizumab (DB00112)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: anti-CD4 monoclonal antibody/prednisolone
Trial: 29570853
Drug: Levodopa-carbidopa intestinal
RxNorm normalized name: carbidopa / levodopa
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levodopa-carbidopa intestinal gel
Trial: 18588355
Drug: Atorvastatin 10
RxNorm normalized name: atorvastatin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin 10 mg once daily
Trial: 18547293
Drug: 3 mg
RxNorm normalized name: boron 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 mg morphine in 10 ml saline
Trial: 12202665
Drug: Temozolomide and
RxNorm normalized name: Temozolomide
DrugBank: Temozolomide (DB00853)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Temozolomide and radiotherapy (75 mg/m(2)/d concurrent with 40‐Gy radiotherapy for 4 weeks, followed by 200 mg/m(2)/d for 5 days every 28 days for 6 cycles)
Trial: 30737098
Drug: Rectal tumors
RxNorm normalized name: human breast tumor cell
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rectal tumors with wild-type KRAS
Trial: 26135689
Drug: Rectal tumors
RxNorm normalized name: human breast tumor cell
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rectal tumors
Trial: 21391015
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (active treatment alternative)
Trial: 11515348
Drug: Lansoprazole suspension
RxNorm normalized name: Lansoprazole
DrugBank: Lansoprazole (DB00448)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lansoprazole suspension
Trial: 24758078
Drug: Dietetic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dietetic therapy and physical exercises (Control)
Trial: 2162439
Drug: Overall response
RxNorm normalized name: Besponsa
DrugBank: Inotuzumab ozogamicin (DB05889)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Overall response to chemotherapy
Trial: 21929838
Drug: Berry meal
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Berry meal (150 g purée of bilberries, blackcurrants, cranberries, and strawberries with 35 g sucrose)
Trial: 19939872
Drug: Midazolam intravenous
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Midazolam intravenous 0.1 mg/kg
Trial: 27378474
Drug: Irbesartan 300
RxNorm normalized name: irbesartan 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Irbesartan 300 mg/day
Trial: 11772142
Drug: Rabeprazole 20
RxNorm normalized name: RABEprazole 20 mg oral delayed release tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rabeprazole 20 to 40 mg/day
Trial: 10963459
Drug: Intravenous ascorbate
RxNorm normalized name: ascorbate
DrugBank: Ascorbic acid (DB00126)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous ascorbate treatment; specific dosage and duration not mentioned.
Trial: 17395894
Drug: Immediate-release methylphenidate
RxNorm normalized name: methylphenidate Extended Release Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate-release methylphenidate (bid)
Trial: 17200303
Drug: Operative treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Operative treatment with plate fixation
Trial: 21420744
Drug: Withdrawal of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Withdrawal of benzodiazepine or related drugs (BZD/BZDRD)
Trial: 10743445
Drug: meloxicam 15
RxNorm normalized name: meloxicam 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: meloxicam 15 mg rectally
Trial: 24906705
Drug: ADSE protocol
RxNorm normalized name: Olay Professional Acne Protocol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ADSE protocol (atropine first, 1.0 mg administered 3 min before dobutamine infusion)
Trial: 21597387
Drug: Linifanib (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Linifanib (both doses)
Trial: 19036981
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg of hydrocortisone
Trial: 19036981
Drug: Both drugs
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both drugs in combination (RBX and hydrocortisone)
Trial: 23787555
Drug: Corticosteroid therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticosteroid therapy (prednisone)
Trial: 8588120
Drug: Aceclofenac 100
RxNorm normalized name: aceclofenac 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aceclofenac 100 mg b.i.d.
Trial: 16490579
Drug: IDD-P fenofibrate
RxNorm normalized name: Fenofibrate
DrugBank: Fenofibrate (DB01039)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: IDD-P fenofibrate 160-mg tablet plus ER niacin 500-mg tablet
Trial: 18234045
Drug: eletriptan 40
RxNorm normalized name: eletriptan 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: eletriptan 40 mg (E40)
Trial: 15995003
Drug: Lactobacillus paracasei
RxNorm normalized name: Lactobacillus Paracasei
DrugBank: Lactobacillus paracasei (DB16551)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lactobacillus paracasei strain ST11 (10^10 CFU daily for 5 days)
Trial: 3540870
Drug: Meclofenamate sodium
RxNorm normalized name: Meclofenamate Sodium
DrugBank: Meclofenamic acid (DB00939)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Meclofenamate sodium 200 mg at dose 1 and 100 mg at doses 2 and 3
Trial: 3540870
Drug: Meclofenamate sodium
RxNorm normalized name: Meclofenamate Sodium
DrugBank: Meclofenamic acid (DB00939)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Meclofenamate sodium 100 mg at dose 1 and 50 mg at doses 2 and 3
Trial: 31039774
Drug: Non-pharmacological treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-pharmacological treatment
Trial: 6965324
Drug: Transcutaneous electrical
RxNorm normalized name: Transcutaneous Electrical Nerve Stimulators (TENS Units) MISCELL EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transcutaneous electrical nerve stimulation (10-minute treatment)
Trial: 21183763
Drug: Aggressive strategy
RxNorm normalized name: ZO SKIN HEALTH Aggressive Anti-Aging Program KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aggressive strategy (same aspirin and clopidogrel as conventional, plus intravenous glycoprotein IIb/IIIa inhibitor)
Trial: 12884888
Drug: Discontinuation of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Discontinuation of imipramine (n = 27)
Trial: 7350901
Drug: Choline chloride
RxNorm normalized name: Choline Chloride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Choline chloride (16 g)
Trial: 3809112
Drug: Triamcinolone administered
RxNorm normalized name: Triamcinolone
DrugBank: Triamcinolone (DB00620)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Triamcinolone administered to pregnant women
Trial: 29493875
Drug: Conventional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatment (oxygen, corticosteroids, bronchodilators, physiotherapy) plus one session of sophrology
Trial: 3114506
Drug: Administration sets
RxNorm normalized name: administration sets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Administration sets replaced at 72-hour intervals
Trial: 23393185
Drug: Insulin degludec
RxNorm normalized name: Insulin Degludec
DrugBank: Insulin degludec (DB09564)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Insulin degludec (IDeg) Forced-Flex once daily
Trial: 26794682
Drug: Dasotraline 16
RxNorm normalized name: Dasotraline
DrugBank: Dasotraline (DB12305)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dasotraline 16 mg
Trial: 10337860
Drug: Exercise and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exercise and alcohol (0.4 g/kg body weight)
Trial: 11870141
Drug: Intravenous immunoglobulin
RxNorm normalized name: Intravenous immunoglobulin (IVIg)
DrugBank: Human immunoglobulin G (DB00028)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous immunoglobulin (IvIg) treatment
Trial: 2047051
Drug: Aloe vera
RxNorm normalized name: ALOE VERA
DrugBank: Aloe vera leaf (DB13906)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aloe vera gel
Trial: 9167772
Drug: Estrogen treatment
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estrogen treatment vs. Orchidectomy
Trial: 22781199
Drug: Nebulized budesonide
RxNorm normalized name: Budesonide
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Nebulized budesonide (BUD) + nebulized 0.5% salbutamol (150 µg/kg) + 0.025% ipratropium bromide (1 ml) + 0.05% budesonide (2 ml)
Trial: 7471712
Drug: Experimental vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Experimental vaccine (A-EV)
Trial: 30187632
Drug: Empagliflozin 10
RxNorm normalized name: empagliflozin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Empagliflozin 10 mg/d, regular group (n = 25)
Trial: 30187632
Drug: Empagliflozin 10
RxNorm normalized name: empagliflozin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Empagliflozin 10 mg/d, intermittent group (n = 25)
Trial: 26952547
Drug: Placebo plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo plus oral prednisolone
Trial: 3688595
Drug: Control phase
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Control phase (baseline aspirin absorption with 2,592 mg aspirin)
Trial: 11555566
Drug: Inhaled tobramycin
RxNorm normalized name: tobramycin Inhalation Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled tobramycin plus standard CF care
Trial: 20018807
Drug: Hibiscus tea
RxNorm normalized name: Hibiscus sabdariffa seed oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hibiscus tea (3 240‐mL servings/d for 6 weeks)
Trial: 6148814
Drug: Low-dose heparin
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose heparin therapy
Trial: 9844044
Drug: Tetravalent (ACYW)
RxNorm normalized name: dengue virus live antigen, CYD serotype 1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tetravalent (ACYW) meningococcal capsular polysaccharide vaccine
Trial: 2647007
Drug: 150 mg
RxNorm normalized name: pectin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg enprofylline twice daily
Trial: 2647007
Drug: 450 mg
RxNorm normalized name: aspirin 450 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 450 mg enprofylline twice daily
Trial: 14696021
Drug: Triazolam 0.25
RxNorm normalized name: triazolam 0.25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triazolam 0.25 mg
Trial: 31477047
Drug: Placebo infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo infusion (discontinued oxytocin)
Trial: 29590534
Drug: Ibuprofen (IBU)
RxNorm normalized name: Ibuprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ibuprofen (IBU) 300 mg
Trial: 9013267
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of right ventricular hypertrophy, right atrial enlargement and right bundle branch block
Trial: 25953357
Drug: Active IOM
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active IOM (3.7 μg/kg) + Active AMPH (0.1 mg/kg)
Trial: 17961721
Drug: Novel drugs
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Novel drugs (bortezomib, thalidomide, lenalidomide)
Trial: 28145158
Drug: Sitagliptin (chronic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sitagliptin (chronic dosing)
Trial: 23076293
Drug: Weekly alendronate
RxNorm normalized name: alendronate
DrugBank: Alendronic acid (DB00630)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Weekly alendronate
Trial: 15301577
Drug: Risperidone 2mg
RxNorm normalized name: RISPERIDONE 2MG TAB
DrugBank: Risperidone (DB00734)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Risperidone 2mg once daily on days 15 and 16, and 4 mg once daily on days 17-28
Trial: 26938953
Drug: Intravitreal anti-VEGF
RxNorm normalized name: Anti-VEGF monoclonal antibody
DrugBank: Bevacizumab (DB00112)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Intravitreal anti-VEGF injections
Trial: 23046029
Drug: Intense pulsed
RxNorm normalized name: Uricalm Intensive
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intense pulsed light (IPL) combined with bleaching agents and broad-spectrum sunscreens
Trial: 10634161
Drug: Magnesium citrate
RxNorm normalized name: Magnesium Citrate
DrugBank: Magnesium (DB14513)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Magnesium citrate (250 mL) and bisacodyl (10 mg, orally)
Trial: 10634161
Drug: Castor oil
RxNorm normalized name: Castor Oil
DrugBank: Castor oil (DB11113)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Castor oil (60 mL, orally)
Trial: 1959859
Drug: Parenteral amino
RxNorm normalized name: parenteral amino acid 7 % comb no.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parenteral amino acid administration
Trial: 29802820
Drug: 200g red
RxNorm normalized name: Red gum
DrugBank: Eucalyptus gum (DB15537)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200g red raspberries (201 mg total (poly)phenols)
Trial: 6626436
Drug: desmethylimipramine (DMI)
RxNorm normalized name: Desmethylimipramine
DrugBank: Desipramine (DB01151)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: desmethylimipramine (DMI) 50 mg
Trial: 18279877
Drug: Early oral
RxNorm normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early oral intake (EOI) group - clear liquid drink given 2 hours after surgery